Tag: CRT 2019

CRT 2019: Evolut R superior to surgery at one year in...

A subanalysis from the SURTAVI trial has found that transcatheter aortic valve implantation (TAVI) with Evolut R in intermediate-risk patients has lower rates of...

CRT 2019: Alert system is safe, quick, and has few complications

The AngelMed Guardian implantable device is as safe as using a pacemaker, with comparably low complication rates, and fewer delays in care than reliance...

CRT 2019: Renal denervation using alcohol “seems very effective”

 The renal denervation bubble collapsed due to a single trial—SYMPLICITY HTN-3, but this trial’s findings went against the grain, Horst Sievert (Frankfurt, Germany) tells...

CRT 2019: Redesigning the resurgence of renal denervation

 David Kandzari (Atlanta, USA) tells Cardiovascular News at CRT 2019 that renal denervation is typically showing magnitudes of blood pressure reduction that are clinically...

CRT 2019: Peregrine catheter demonstrated 100% procedural success in post-market clinical...

The Peregrine system infusion catheter (Ablative Solutions) has demonstrated 100% procedural success in the Peregrine post-market clinical trial, new data presented during a late-breaking...

CRT 2019: Early resorption and low complications demonstrated for Magmaris

A press release reports that preliminary data from the BIOSOLVE-IV registry strengthen the clinical evidence in favour a bioresorbable magnesium scaffold (Magmaris, Biotronik) for...

CRT 2019: Three-year data shows trend towards lower target vessel failure...

Three-year outcome data from the BIO-RESORT randomised controlled trial, which were presented at the 2019 Cardiovascular Research Technologies (CRT) meeting (2–5 March, Washington, DC,...

CRT 2019: US FDA approves resting full-cycle ratio for measuring severity...

Abbott has announced the US FDA clearance of the resting full-cycle ratio (RFR) diagnostic test to identify significant narrowing of arteries in patients with...